Back to stocks
DMAC

DMAC

DiaMedica Therapeutics Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
13
Partial Q3 2026
Total 13F value
$1.5M
Filed positions so far
New positions
4
This quarter
Sold positions
2
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Members Wealth Llc

$810K101.4K0.40%Unchanged

Blue Trust, Inc.

$572K69.1K0.01%Unchanged

Massmutual Private Wealth & Trust, Fsb

$40K4.8K0.00%Unchanged

Farther Finance Advisors, Llc

$39K4.7K0.00%+11.1%

Strs Ohio

$26K3.2K0.00%+39.1%

Gk Wealth Management Llc

$23K2.8K0.01%New Position

Sterling Capital Management Llc

$10K1.2K0.00%+831.8%

Td Waterhouse Canada Inc.

$9K1.1K0.00%Unchanged

Gamma Investing Llc

$4K4260.00%+109.8%

Sjs Investment Consulting Inc.

$8611040.00%New Position

Sbi Securities Co., Ltd.

$8271000.00%New Position

Caitong International Asset Management Co., Ltd

$149180.00%+63.6%

Root Financial Partners, Llc

$132160.00%New Position

Explore